You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Belarus

Aug 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Belarus with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Belarus, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Belarus for free:

The Consumer Health in Belarus market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Belarus?
  • What are the major brands in Belarus?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Growth limited to increase in value sales

Consumer health only recorded value growth in 2010, with volume sales stagnating. Whilst consumer health volume sales increased in 2006, 2007 and 2008, they declined in 2009 and 2010. Value growth in 2010 was lower than in 2009 when there was a major increase in prices due to the 20% devaluation of the national currency on the 1 January 2009. Several measures were taken by local authorities during 2009 and 2010 in order to minimise the increase in the price of consumer health products, including the widening range of locally produced products (prices of which are regulated by the Ministry of Economics) from 128 to 221 brands and the signing of “The Memorandum of Price Restraints” by the Ministry of Health of Belarus and key pharmaceutical players.

Rising unit prices due to inflation and devaluation of national currency

According to local authorities, the Belarusian economy started to recover from the financial crisis at the end of 2010. However, inflation of 8-10% in 2010 will increase the price of many fast-moving consumer goods, including drugs. In addition, the devaluation of the national currency against the Euro and US dollar and high dependence on imported products will also put upwards pressure on unit prices.

International pharmaceutical manufacturers continue to dominate sales

According to the Ministry of Statistics of Belarus, locally produced products account for just 20% of consumer health sales in Belarus. Of the 6,000 officially registered consumer health products available in Belarus, only 1,000 are locally produced.

The Belarusian authorities are using administrative resources in order to increase sales of locally produced drugs, with measures introduced in 2009 and 2010 including further limitations regarding state expenditure on drugs and medical equipment. Documents from the Ministry of Health oblige suppliers of drugs and medical equipment to give preference to locally produced products, even if they are up to 15% more expensive than imported alternatives.

Another tool used by the authorities to protect local consumer health products in Belarus is the limiting of retail and wholesale mark-ups. Mark-ups also depend on the manufacturer selling price (MSP). The higher the MSP, the lower mark-ups are allowed to be. This regulation mainly affects imported drugs which are more expensive than locally produced ones. For example, if a product costs more than USD100, then its maximum wholesale mark-up is limited to 4% whilst the maximum retail mark-up is limited to 2%.

Despite the difficulties they face in Belarus, international pharmaceutical manufacturers allow their representatives in the country to offer additional discounts in order to maintain their sales shares.

Distribution mainly limited to chemists

The government in Belarus maintains a firm grip on the distribution of all pharmaceutical goods, including OTC products, with sales only being allowed through chemists and pharmacies or pharmacies and drugstores. Most products may only be sold via chemists and pharmacies, with such outlets dominating value sales at the end of the review period. As a result, the presence of pharmacies and drugstores in Belarus is insignificant. No OTC products are available through other channels such as supermarkets, hypermarkets, the internet or via direct sellers.

Good growth opportunities

Despite the current difficulties, the Belarusian pharmaceutical industry has a promising future. Indeed, according to a number of sources, total pharmaceutical value sales in Belarus are expected to reach over USD1 billion by 2013. OTC healthcare in Belarus has more scope for value as opposed to volume growth due to rising unit prices and the increasing popularity of self-medication and high dependence on imports.

Via its “producing import replacements” programme, the government will support national manufacturers and their products over the coming years. This will result in the sales share of locally produced products reaching up to 50% by 2013 according to the Ministry of Health.

Table of Contents

Table of Contents

Consumer Health in Belarus - Industry Overview

EXECUTIVE SUMMARY

Growth limited to increase in value sales

Rising unit prices due to inflation and devaluation of national currency

International pharmaceutical manufacturers continue to dominate sales

Distribution mainly limited to chemists

Good growth opportunities

KEY TRENDS AND DEVELOPMENTS

Strong government regulation

Health expenditure and GDP

Retailing of drugs in Belarus

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Generics

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Belarus - Company Profiles

Belmedpreparaty RUE in Consumer Health (Belarus)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Belmedpreparaty RUE: Competitive Position 2010

Borisov Medical Preparations Plant in Consumer Health (Belarus)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Borisov Medical Preparations Plant OJSC: Competitive Position 2010

Pharmland JV Ltd in Consumer Health (Belarus)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Pharmland JV Ltd: Competitive Position 2010

Adult Mouth Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • The willingness of consumers to self-medicate depends on the condition they are suffering from. In the case of throat inflammation or milder conditions, consumers use OTC products or even home remedies. Long cold winter seasons increase oral problems such as throat inflammation. As a result, oral sprays and liquid mouthwash remedies are increasing in popularity, especially during the cold season and amongst urban citizens concerned with their health and image. Self-medication is popular within adult mouth care for the treatment of mild problems. However, consumers are quick to consult a doctor when suffering from more severe conditions such as ulcers or a high level of pain.

COMPETITIVE LANDSCAPE

  • Since the number of brands available within adult mouth care is limited, competition is weak, with ICN Pharmaceutical dominating sales in 2010 with a retail value share of 51%. ICN Pharmaceutical was also the best performing company in 2010, increasing its retail value share by one percentage point. The company’s Solcoseryl brand is well-known amongst consumers in an area where brand awareness and recognition is minimal.

PROSPECTS

  • Adult mouth care has a projected forecast period constant retail value CAGR of 2%. Growth over the coming years will be fuelled by increasing unit prices as a result of rising import costs due to the on-going devaluation of the local currency. In addition, rising product awareness will also fuel demand over the coming years.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Belarus - Category Analysis

HEADLINES

TRENDS

  • Combination products with acetaminophen continued to increase in popularity in 2010 due to the strong flu epidemic in autumn 2009 and winter 2010 and the very cold winter in 2010. Combination products, mainly with vitamin C added, were widely used as analgesics and cold and flu treatments, with demand being boosted by the self-medication trend.

COMPETITIVE LANDSCAPE

  • Borisov Medical Preparations Plant led analgesics in 2010, recording a retail value share of 15% and was followed by Belmedpreparaty (12%). Brands from these two local leading producers are popular amongst Belarusian consumers due to their affordability and the fact that many people, particularly elderly and rural consumers, prefer the traditional aspirin and analgin products offered by domestic players.

PROSPECTS

  • Analgesics has a projected forecast period constant retail value CAGR of 4%. The high dependence on imports and the on-going devaluation of the local currency as well as the fact that consumers are switching to higher quality and less harmful analgesics will underpin value growth over the coming years. On the other hand, the government’s efforts to restrain price growth and to support local manufacturers and their products, which are several times cheaper than imported brands, will slow down value growth. The Belarusian economy is expected to improve over the forecast period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Belarus - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping recorded current retail value growth of 10% in 2010, with sales being fuelled by rising stress levels and longer working hours. In addition, increasing urbanisation and rising night-time noise levels in urban areas also contributed to growth. Meanwhile, sales of child-specific products also increased as children were increasingly left overexcited by computer games and TV.

COMPETITIVE LANDSCAPE

  • Ivax Corp led sales in 2010, recording a retail value share of 20%, and also recorded the largest increase in sales share. The company’s Novo-Passit brand is well known, well-advertised and highly popular amongst consumers.

PROSPECTS

  • Calming and sleeping has a projected forecast period constant retail value CAGR of 2%. Growth will be supported by a continuing increase in stress levels among consumers and longer working days in major cities – developments that will result in rising anxiety and sleep disturbance.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Belarus - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies are seasonable products in Belarus, with sales of cough and cold products increasing in autumn and winter and sales of allergy products peaking in late spring and summer. The performance of the area usually depends on the severity of the winter and autumn seasons. The fact that there was a major cold and flu epidemic in Belarus in autumn 2009 and winter 2010 boosted demand within the area during 2010. Combination products and cough remedies continued to lead sales during 2010. Due to the increasingly hectic pace of modern life in Belarus, demand for OTC cough and cold remedies is increasing. Local consumers prefer OTC products to prescribed drugs as they do not like to waste time waiting to see a doctor and instead seek qualified advice from pharmacists.

COMPETITIVE LANDSCAPE

  • Novartis and Egis led cough, cold and allergy (hay fever) in 2010, each recording a retail value share of 9%, and were followed by GlaxoSmithKline (8%). These companies benefit from the popularity of their respective well-known Theraflu, Suprastin and Coldrex brands which enjoy a high level of advertising support.

PROSPECTS

  • Cough and cold remedies will always be in high demand in Belarus due to the country’s harsh climatic conditions and cold and wet winter seasons. However, growth is difficult to estimate as outbreaks of flu have a major impact on sales, which vary from year to year. Combination products and cough remedies will remain the largest product areas over the forecast period, with products in these areas being widely used to reduce symptoms and enable consumers to continue working while suffering from cold or flu symptoms. The area has a projected forecast period constant retail value CAGR of 4%.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Belarus - Category Analysis

HEADLINES

TRENDS

  • Despite rising awareness of the importance of leading a healthier lifestyle in large cities, outside these areas consumers are less concerned with nutrition and often suffer the negative consequences of poor hygiene and high fat diets. Also, in large cities the popularity of slimming diets is the cause of various digestive disorders. In addition, smoking, alcohol consumption, and rising stress levels for urban residents all contribute to increasing demand for digestive products. The fact that the population in Belarus is ageing is also helping to boost demand for digestive remedies. As a result, demand for indigestion and heartburn remedies in the country remains strong, with current retail value sales increasing by some 10% in 2010. Indigestion and heartburn remedies remain the largest areas within digestive remedies, accounting for 52% of total value sales in 2010.

COMPETITIVE LANDSCAPE

  • Berlin-Chemie maintained its leading position within digestive remedies in 2010, recording a retail value share of 19%. The company continues to benefit from the recognition enjoyed by its Mezim Forte brand which enjoys a high level of popularity among urban citizens and is supported by massive advertising campaigns. In addition, Berlin-Chemie also recorded the largest increase in current retail value sales in 2010. Sanofi-Aventis ranked second in 2010 and was followed by Lek Pharmaceuticals and Beaufour-Ipsen, with all three companies recording a retail value share of 8%.

PROSPECTS

  • Digestive remedies has a projected forecast period constant retail value CAGR of 2%. The high incidence of digestive ailments in Belarus due to the traditionally high-fat diet in the country will fuel growth over the coming years. In addition, high levels of alcohol and tobacco consumption and the increasingly stressful pace of modern life will also fuel growth within digestive remedies.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • Ear care recorded current retail value growth of 10% in 2010, with sales reaching BYR1.4 billion. As in eye care, consumers suffering from ear ailments typically prefer to seek advice from a doctor instead of self-medicating, with doctors often recommending more expensive but more effective remedies with fewer side effects. The fact that consumers typically use Rx medication to treat ear care problems hampers the potential for OTC ear care growth.

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis led sales in 2010, recording a retail value share of 23%, and was followed by ICN Pharmaceutical (18%). Local company Belmedpreparaty ranked third with a retail value share of 12%. In general, brand awareness is relatively low, with numerous local unbranded products being popular among elderly consumers, particularly in rural areas.

PROSPECTS

  • Ear care has a projected forecast period constant retail value CAGR of 2%. Growth over the coming years will mainly be fuelled by the continued shift towards higher quality and more expensive brands from multinational players and leading local companies.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Belarus - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception in Belarus remains underdeveloped, with only a few brands being widely recognised. However, the area recorded current retail value growth of 10% in 2010, with sales reaching over BYR2 billion.

COMPETITIVE LANDSCAPE

  • Richter Gedeon’s Postinor and Escapelle brands are the only emergency contraception products that are widely available in Belarus. The company accounted for the majority of emergency contraception sales in Belarus in 2010.

PROSPECTS

  • Emergency contraception has a projected forecast period constant retail value CAGR of 2%. Producers will focus on marketing and consumer educational campaigns in order to stimulate demand over the coming years, with sales expected to remain concentrated in larger cities.

CATEGORY DATA

  • Table 47 Sales of Emergency Contraception: Value 2005-2010
  • Table 48 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 49 Emergency Contraception Company Shares 2006-2010
  • Table 50 Emergency Contraception Brand Shares 2007-2010
  • Table 51 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 52 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • The increasing popularity of eye dietary supplements continued to hamper eye care products OTC sales during 2010. Dietary supplements are perceived as being less harmful and are consumed on a regular basis while OTC preparations are only used to treat actual problems.

COMPETITIVE LANDSCAPE

  • The number of brands and players within eye care in 2010 was limited. Consumers are not willing to self-medicate in this area, with most people preferring to seek professional advice before treatment. Relatively easy access to ophthalmologists enables many people suffering from eye problems to receive expert advice and, frequently, a prescription for treatment. This is why there are more Rx brands than OTC products in the area. The leading companies in the area in 2010 were Alcon Universal and Santen Pharmaceutical, both of which recorded retail value shares of 17%.

PROSPECTS

  • Eye care has a projected forecast period constant retail value CAGR of 4%. Growth in the area will mainly be fuelled by rising unit prices due to increasing import costs as a result of the on-going devaluation of the local currency and rising demand for higher quality products.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares 2006-2010
  • Table 57 Eye Care Brand Shares 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Belarus - Category Analysis

HEADLINES

TRENDS

  • Herbal and traditional products sales increased during 2010 due to growing consumer trust in products in this area, especially since such products are cheaper than synthetic drugs.

COMPETITIVE LANDSCAPE

  • International companies dominated sales in 2010. However, the position of domestic companies improved as a result of the government’s “Production of import replacement products” programme.

PROSPECTS

  • Herbal and traditional products has a projected forecast period constant retail value CAGR of 4%, with herbal cough, cold and allergy (hay fever) products, calming and sleeping products and herbal dietary supplements supporting growth. Increasing awareness of the importance of leading a healthy lifestyle will continue to raise demand for herbal and traditional products in Belarus. These products are considered to be healthier alternatives to chemical-based drugs, with fewer or no side effects, and are very important to key consumer groups – children, elderly people and rural consumers.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • A widening product range and rising consumer product awareness fuelled growth in 2010. In addition, rising self-medication also supported growth. The fact that many consumers view skin ailments as being rather embarrassing means that they often prefer to purchase well-promoted OTC products based on their own experience, advertising and advice from pharmacists. Rising urban population and stress levels in Belarus are also resulting in an increase in the incidence of skin problems. As a result, the majority of consumers of medicated skin care products in Belarus are urban citizens of all ages.

COMPETITIVE LANDSCAPE

  • Richter Gedeon dominated sales in 2010, recording a retail value share of 20%. The company offers successful brands within all large medicated skin care areas. For example, Curiosin accounted for 63% of retail value sales within acne treatments, Terbisil accounted for 38% of topical antifungal retail value sales and Gynofort accounted for 27% of vaginal antifungal retail value sales. All of these brands enjoy a high level of recognition amongst consumers in Belarus.

PROSPECTS

  • Medicated skin care will continue to record healthy growth over the forecast period and has a projected constant retail value CAGR of 3%. The fact that most areas remain underdeveloped and that there is only a limited number of brands available means that there is still significant scope for growth.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares 2007-2010
  • Table 70 Hair Loss Treatments Brand Shares 2007-2010
  • Table 71 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 72 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Belarus - Category Analysis

HEADLINES

TRENDS

  • Cigarette volume sales reached 21.6 billion sticks in Belarus in 2009. Whilst the number of male and female smokers dropped slightly, over two million people in the country continue to smoke. The number of male smokers in 2009 was more than five times higher than the number of female smokers, with 48% of men in the country and just 8% of females being smokers. However, the number of deaths from smoking-related illnesses per 100,000 inhabitants is growing despite government efforts to lower the smoking rate. Heart disease accounts for some 85% of deaths from smoking-related illnesses in Belarus. Other smoking-related illnesses include diseases of the respiratory system and lung cancer, which account for 10% and 5% of smoking-related deaths in Belarus respectively.

SWITCHES

COMPETITIVE LANDSCAPE

  • NRT smoking cessation aids were only introduced in 2001 and continue to suffer from a lack of competition.

PROSPECTS

  • NRT smoking cessation aids has a projected forecast period constant retail value CAGR of 1%. Growth within the area will be very slow over the coming years due to the very limited product choice within the area and strong competition from products in other areas.

CATEGORY INDICATORS

  • Table 73 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 74 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 75 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 76 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 77 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 78 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Belarus - Category Analysis

HEADLINES

TRENDS

  • Demand for sports nutrition products remained limited to sportsmen and professional sport trainers in 2010, with the majority of consumers in Belarus remaining unaware of the availability of such products.

COMPETITIVE LANDSCAPE

  • In 2010, products from the following companies were available in this area: Universal Nutrition, Dymatize, Maxler and Optimum Nutrition.

PROSPECTS

  • The situation within sports nutrition is unlikely to change over the forecast period as demand for products in this area remains limited to sportsmen and professional sport trainers, with awareness of such products amongst the majority of the population expected to remain very low. The fact that only imported brands are available means that products remain too expensive for the majority of consumers in the country.

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition: Value 2005-2010
  • Table 82 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 83 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 84 Sports Nutrition Company Shares 2006-2010
  • Table 85 Sports Nutrition Brand Shares 2007-2010
  • Table 86 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Belarus - Category Analysis

HEADLINES

TRENDS

  • Growth within vitamins and dietary supplements is being supported by the healthy life-style trend. However, this trend is mainly limited to urban areas, with most consumers in rural areas still have relatively low awareness of the benefits of the consumption of vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Competition in 2010 was tight within vitamins and dietary supplements, with Nycomed leading sales with a retail value share of 15%. Minskintercaps and Krka each recorded a retail value share of 7% and were followed by Sagmel (6%), Malkut (6%) and Unipharm (5%). Nycomed’s success can be attributed to its leadership within dietary supplements, where the company recorded a retail value share of 25% in 2010, and vitamins (12%). This good performance was due to the company’s investment in advertising, offering of competitive prices, and positioning of its products in the most popular medium price segment.

PROSPECTS

  • Vitamins and dietary supplements has a projected forecast period constant retail value CAGR of 2%, with growth within dietary supplements expected to be slightly lower than that within vitamins. Within vitamins, vitamins complexes will record higher growth than single vitamins.

CATEGORY DATA

  • Summary 8 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 88 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 90 Dietary Supplements by Positioning 2006-2010
  • Table 91 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 92 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 93 Vitamins Brand Shares 2007-2010
  • Table 94 Dietary Supplements Brand Shares 2007-2010
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Belarus - Category Analysis

HEADLINES

TRENDS

  • Slimming products continue to increase in popularity in Belarus due to the growing number of overweight people in the country. Slimming products are a good alternative to obesity products, which are only available in limited numbers and are perceived as being expensive by consumers. Although local people are concerned about their health and appearance, per capita sales of slimming products remain low in Belarus, with the majority of the population still preferring to reduce food consumption or to go to sports clubs instead of purchasing slimming products on a regular basis.

COMPETITIVE LANDSCAPE

  • Russian company Evalar led sales in 2010, recording a retail value share of 51% and also recorded the largest increase in retail value share (two percentage points). This good performance was due to the popularity of the company’s brands, especially Turboslim. Evalar’s products are not expensive compared to those of its competitors – a fact which is highly important given current economic conditions. In addition, the fact that the company continues to introduce new and innovative products helps to maintain consumer interest and loyalty.

PROSPECTS

  • The perception of slimming products is expected to change over the forecast period. With the increasing consumption of packaged food and decreasing physical activity, demand for slimming products is expected to increase over the forecast period. Over the coming years, dieting, physical exercise and balanced nutrition will remain popular among overweight women. However, women will increasingly combine diets with slimming products in order to make dieting easier and more effective. As a result, weight management has a healthy projected forecast period constant retail value CAGR of 4%.

CATEGORY DATA

  • Table 97 Sales of Weight Management by Category: Value 2005-2010
  • Table 98 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 99 Weight Management Company Shares 2006-2010
  • Table 100 Weight Management Brand Shares 2007-2010
  • Table 101 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 102 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • Wound care records current retail value growth of 10% in 2010, with sales reaching BYR11 billion. Growth was largely driven by rising demand for more convenient products. The share of more expensive products continues to steadily increase within wound treatments, especially within sticking plasters. In 2010, sticking plasters accounted for 63% of wound care current retail value sales in Belarus - a one percentage point rise from 2009.

COMPETITIVE LANDSCAPE

  • Russian company Veropharm led sales in 2010, recording a retail value share of 16%, and was followed by Evers-Pharm (10%). Veropharm recorded the largest increase in retail value share in 2010. Veropharm mainly competes within sticking plasters, which is growing more rapidly than gauze, tape and other wound care. The company’s Veropharm brand is well-known in Belarus and is cheaper than other sticking plaster brands. Overall, a large number of brands are available within wound care, with unbranded products leading sales.

PROSPECTS

  • Wound care has a projected forecast period constant retail value CAGR of 2%. Growth will be fuelled by unit price increases and rising demand for more expensive value-added products.

CATEGORY DATA

  • Table 103 Sales of Wound Care by Category: Value 2005-2010
  • Table 104 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 105 Wound Care Company Shares 2006-2010
  • Table 106 Wound Care Brand Shares 2007-2010
  • Table 107 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 108 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Future Demographic

      Consumer Lifestyle

      Country Report